공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 피하 삽입 피임약 시장 : 지역별, 부문 예측 - 시장 규모, 점유율, 동향(2019-2026년)

Subdermal Contraceptive Implants Market Size, Share & Trends Analysis Report By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2019 - 2026

리서치사 Grand View Research, Inc.
발행일 2019년 12월 상품 코드 923755
페이지 정보 영문 80 Pages
가격
US $ 5,950 ₩ 6,815,000 Unprintable PDF (Single User License)
US $ 6,950 ₩ 7,961,000 Printable PDF (5-User License)
US $ 8,950 ₩ 10,252,000 Printable PDF (Enterprise License)


세계의 피하 삽입 피임약 시장 : 지역별, 부문 예측 - 시장 규모, 점유율, 동향(2019-2026년) Subdermal Contraceptive Implants Market Size, Share & Trends Analysis Report By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2019 - 2026
발행일 : 2019년 12월 페이지 정보 : 영문 80 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 피하 삽입 피임약(Subdermal Contraceptive Implants) 시장은 예측 기간 중 3.2%의 CAGR로 성장할 전망이며, 2026년에는 9억 6,920만 달러에 달할 것으로 예측되고 있습니다. 현대 피임약의 시장에 대한 도입, 다양한 피임 방법에 대한 인식 향상, 1인당 수입 증가는 이 시장을 촉진하고 있는 주요 요인의 일부입니다.

세계의 피하 삽입 피임약 시장에 대해 조사했으며, 시장 동향 및 전망, 지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 조사 방법 및 범위

  • 시장 세분화 및 범위
  • 조사 방법
  • 정보 조달
  • 정보 또는 데이터 분석
  • 시장 정식화와 검증
  • 모델 상세 내역
  • 2차 자료 리스트
  • 1차 자료 리스트
  • 약어 목록
  • 조사 목적

제2장 개요

  • 시장 전망
  • 부문 전망
  • 경쟁 인사이트

제3장 시장 변수, 동향 및 범위

  • 시장계의 전망
  • 시장 세분화
  • 시장 역학
  • 비지니스 환경 분석 툴
  • 주요 거래와 전략적 제휴 분석
  • 파이프라인 분석

제4장 시장 분석 : 지역별

  • 시장 점유율 분석(2018년 및 2026년)
  • 부문 대시보드
  • 시장의 스냅숏(시장 규모, CAGR, 상위 산업, 주요 기업, 상위 동향)
  • 시장 규모 예측, 동향 분석(2015-2026년)

제5장 경쟁 구도

  • 최근 개발과 영향 분석 : 주요 시장 진출 기업별
  • 전략적 프레임워크/경쟁 분류(주요 이노베이터, 시장 리더, 신규 기업)
  • 공영기업과 민간 기업
  • 공급 업체/도매업체 출하 데이터
  • 기업 개요

제6장 KoL 해설

  • KoL 해설
KSA 20.02.26

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviation
  • TABLE 3 Characteristics of different subdermal contraceptive implants
  • TABLE 4 Supply chain contraceptive shipment details

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market outlook
  • Fig. 9 Contraceptive implants market segmentation
  • Fig. 10 Market trends & outlook
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 PESTEL analysis
  • Fig. 15 Subdermal contraceptive implants regional market share analysis, 2018 & 2026
  • Fig. 16 Subdermal contraceptive implants regional market: Segment dashboard
  • Fig. 17 Regional marketplace: Key takeaways
  • Fig. 18 North America subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 19 U.S. subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 20 Canada subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 21 Europe subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 22 Germany subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 23 U.K. subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 24 France subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 25 Italy subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 26 Spain subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 27 Asia Pacific subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 28 China subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 29 India subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 30 Japan subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 31 Latin America subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 32 Brazil subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 33 Mexico subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 34 MEA subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 35 South Africa subdermal contraceptive implants market, 2015 - 2026 (USD Million)
  • Fig. 36 Recent developments
  • Fig. 37 Strategy framework
  • Fig. 38 Strategy mapping
  • Fig. 39 Company market position analysis ( Market presence, geographical presence, product portfolio, & strategic initiatives)
  • Fig. 40 Top 10 FP2020 countries in terms of contraceptives supplier-shipment values, 2017
  • Fig. 41 KoL commentary

The global subdermal contraceptive implants market size is expected to reach USD 969.2 million by 2026, according to a new report by Grand View Research, Inc., registering a 3.2% CAGR over the forecast period. Introduction of several modern contraceptives in the market, growing awareness about various birth control methods, and high per capita income are some of the key factors driving the market for subdermal implants for birth control.

According to the Guttmacher Institute, in 2014, approximately 20 million women needed publicly funded contraceptive services. According to CDC, in 2017, nearly 46.9 million women in the U.S. were using at least one method of contraception. Subdermal implant is a long-term birth control option for women. Subdermal implants for contraception are in the form of polymer capsules or rods placed under the skin. The progestational hormone is released at a slow and stable rate, providing effective contraception for 1-5 years.

Publicly funded family planning services help women avoid or plan pregnancies. In 2012, the South Carolina Department of Health and Human Services (SCDHHS) revised the cost associated with Medicaid payment policy for immediate postpartum insertion of Long-Acting Reversible Contraception (LARC). Under this new reimbursement policy, providers are allowed to bill for the insertion procedure and the cost of an IUD or an implant, in addition to the Diagnosis Related Group (DRG) by using J-codes with a family planning modifier.

Implants are the most widely used contraceptive methods by women in sub-Saharan Africa owing to public-private partnerships between manufacturers, donors, governments, and international agencies, which helps lower commodity cost and increase product availability. Contraceptive usage has increased in South Africa, Malawi, and Rwanda. According to PLOS.org, in Malawi, the use of the Long-acting Reversible Contraception (LARC) method reached 10.21% in urban areas in 2016 and 9.66% in rural areas. In 2012, an initiative called Family Planning 2020 (FP2020) was launched to give 120 million women access to modern contraceptive methods by 2020.

Further key findings from the report suggest:

  • North America held the maximum share in the market for subdermal implants for contraception in 2018. This can be attributed to growing number of unwanted pregnancies, increased government initiatives in favor of contraception, and rising unmet needs
  • Strong economic growth in countries such as China, India, and Singapore, increasing awareness about contraceptives and STIs, and rising disposable income are expected to boost the Asia Pacific market in the coming years
  • Rapid population growth is a major concern in sub-Saharan African countries; the region's population growth is projected to account for more than half of the global population growth by 2050. This could have a positive impact on the uptake of subdermal implants for birth control
  • Some of the key subdermal contraceptive implants market players are Shanghai Dahua Pharmaceutical Co., Ltd.; Merck & Co., Inc.; and Bayer AG. In February 2018, Shanghai Dahua Pharmaceutical Co., Ltd. and DKT International entered into an agreement to market Levoplant at a reduced price of USD 6.90 per unit in 69 countries.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Regional Scope
    • 1.1.2 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
    • 1.6.2 Variable analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective - 1
    • 1.10.2 Objective - 2

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
    • 2.2.1 Region
  • 2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage outlook
    • 3.1.1 Parent market outlook
  • 3.2 Market Segmentation
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Rise in the number of initiatives to promote contraceptive methods
      • 3.3.1.2 Increasing number of unwanted pregnancies
    • 3.3.2 Market restraint analysis
      • 3.3.2.1 Rapidly aging population and rising prevalence of infertility
      • 3.3.2.2 Lack of awareness and adverse effects of contraceptive implants
  • 3.4 Business Environment Analysis Tools
    • 3.4.1 Porter's five forces analysis
    • 3.4.2 PESTEL analysis
  • 3.5 Major Deals & Strategic Alliances Analysis
  • 3.6 Pipeline Analysis

Chapter 4 Contraceptive Implants Market: Regional Analysis

  • 4.1 Contraceptive Implants Regional Market Share Analysis, 2018 & 2026
  • 4.2 Contraceptive Implants Regional Market: Segment Dashboard
  • 4.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
  • 4.4 Market Size, Forecasts, and Trend Analysis, 2015 to 2026
    • 4.4.1 North America
      • 4.4.1.1 North America contraceptive implants market, 2015 - 2026 (USD Million)
      • 4.4.1.2 U.S.
      • 4.4.1.2.1 Regulatory and reimbursement scenario
      • 4.4.1.2.2 U.S. contraceptive implants market, 2015 - 2026 (USD Million)
      • 4.4.1.3 Canada
      • 4.4.1.3.1 Regulatory and reimbursement scenario
      • 4.4.1.3.2 Canada contraceptive implants market, 2015 - 2026 (USD Million)
    • 4.4.2 Europe
      • 4.4.2.1 Europe contraceptive implants market, 2015 - 2026 (USD Million)
      • 4.4.2.2 Germany
      • 4.4.2.2.1 Regulatory and reimbursement scenario
      • 4.4.2.2.2 Germany contraceptive implants market, 2015 - 2026 (USD Million)
      • 4.4.2.3 U.K.
      • 4.4.2.3.1 Regulatory and reimbursement scenario
      • 4.4.2.3.2 U.K. contraceptive implants market, 2015 - 2026 (USD Million)
      • 4.4.2.4 France
      • 4.4.2.4.1 Regulatory and reimbursement scenario
      • 4.4.2.4.2 France contraceptive implants market, 2015 - 2026 (USD Million)
      • 4.4.2.5 Italy
      • 4.4.2.5.1 Regulatory and reimbursement scenario
      • 4.4.2.5.2 Italy contraceptive implants market, 2015 - 2026 (USD Million)
      • 4.4.2.6 Spain
      • 4.4.2.6.1 Regulatory and reimbursement scenario
      • 4.4.2.6.2 Spain contraceptive implants market, 2015 - 2026 (USD Million)
    • 4.4.3 Asia Pacific
      • 4.4.3.1 Asia Pacific contraceptive implants market, 2015 - 2026 (USD Million)
      • 4.4.3.2 Japan
      • 4.4.3.2.1 Regulatory and reimbursement scenario
      • 4.4.3.2.2 Japan contraceptive implants market, 2015 - 2026 (USD Million)
      • 4.4.3.3 China
      • 4.4.3.3.1 Regulatory and reimbursement scenario
      • 4.4.3.3.2 China contraceptive implants market, 2015 - 2026 (USD Million)
      • 4.4.3.4 India
      • 4.4.3.4.1 Regulatory and reimbursement scenario
      • 4.4.3.4.2 India contraceptive implants market, 2015 - 2026 (USD Million)
    • 4.4.4 Latin America
      • 4.4.4.1 Latin America contraceptive implants market, 2015 - 2026 (USD Million)
      • 4.4.4.2 Brazil
      • 4.4.4.2.1 Regulatory and reimbursement scenario
      • 4.4.4.2.2 Brazil contraceptive implants market, 2015 - 2026 (USD Million)
      • 4.4.4.3 Mexico
      • 4.4.4.3.1 Regulatory and reimbursement scenario
      • 4.4.4.3.2 Mexico contraceptive implants market, 2015 - 2026 (USD Million)
    • 4.4.5 Middle East and Africa
      • 4.4.5.1 MEA contraceptive implants market, 2015 - 2026 (USD Million)
      • 4.4.5.2 South Africa
      • 4.4.5.2.1 Regulatory and reimbursement scenario
      • 4.4.5.2.2 South Africa contraceptive implants market, 2015 - 2026 (USD Million)

Chapter 5 Competitive Analysis

  • 5.1 Recent developments & impact analysis, by key market participants
  • 5.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
    • 5.2.1 Strategy Mapping
  • 5.3 Public and Private Companies
    • 5.3.1 Company market position analysis (Overall market presence, geographic presence, product portfolio, and Strategic Initiatives)
  • 5.4 Supplier/Distributor Shipment Data
    • 5.4.1 Top 10 FP2020 Countries in terms of contraceptives supplier-shipment values, 2017
  • 5.5 Company Profiles
    • 5.5.1 Bayer AG
      • 5.5.1.1 Company overview
      • 5.5.1.2 Financial performance
      • 5.5.1.3 Product benchmarking
      • 5.5.1.4 Strategic initiatives
      • 5.5.1.5 SWOT analysis
    • 5.5.2 Merck & Co., Inc.
      • 5.5.2.1 Company overview
      • 5.5.2.2 Financial performance
      • 5.5.2.3 Product benchmarking
      • 5.5.2.4 Strategic initiative
      • 5.5.2.5 SWOT analysis
    • 5.5.3 Shanghai Dahua Pharmaceutical Co., Ltd.
      • 5.5.3.1 Company overview
      • 5.5.3.2 Product benchmarking
      • 5.5.3.3 Strategic initiatives
      • 5.5.3.4 SWOT analysis

Chapter 6 KoL Commentary

  • 6.1 KoL Commentary
Back to Top
전화 문의
F A Q